Axonis Therapeutics Announces $115 Million Series A Financing — Oversubscribed financing brings together leading syndicate of life sciences investors —
Businesswire reports emerging biotechnology company AXONIS Therapeutics, Inc. has secured an additional $5 million in funding and provided an update
The Massachusetts Life Sciences Center (MLSC) named Axonis, Inc. CEO Joanna Stanicka a 2020 winners of the Massachusetts Next Generation
AXONIS are delighted to be awarded the Astellas-sponsored “Golden Ticket Competition.” A Golden Ticket award offers entrepreneurial scientists or emerging biotechnology startups one-year
May 28: AXONIS Therapeutics, Inc. announces the close of the first tranche of a $4 million Seed Preferred financing.
The International Space Station (ISS) U.S. National Laboratory and Boeing [NYSE: BA] have partnered for the sixth consecutive year to
Congratulations to Axonis, the winner of our latest Innovation Prize in Boston for their work in neuro-restorative research in spinal